Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy

Engineered regulatory T cell (Treg cell) therapy is a promising strategy to treat patients suffering from inflammatory diseases, autoimmunity, and transplant rejection. However, in many cases, disease-related antigens that can be targeted by Treg cells are not available. In this study, we introduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Bittner, Sebastian, Ruhland, Brigitte, Hofmann, Veronika, Schmidleithner, Lisa, Schambeck, Kathrin, Pant, Asmita, Stüve, Philipp, Delacher, Michael, Echtenacher, Bernd, Edinger, Matthias, Hoffmann, Petra, Rehli, Michael, Gebhard, Claudia, Strieder, Nicholas, Hehlgans, Thomas, Feuerer, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546553/
https://www.ncbi.nlm.nih.gov/pubmed/36161919
http://dx.doi.org/10.1073/pnas.2208436119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546553/
https://www.ncbi.nlm.nih.gov/pubmed/36161919
http://dx.doi.org/10.1073/pnas.2208436119

Ejemplares similares